The Elimination of Indigenous Measles, Mumps, and Rubella from Finland by a 12-Year, Two-Dose Vaccination Program

New England Journal of Medicine

Volumn 331, Issue 21, 1994, Pages 1397-1402

  Peltola, Heikki ^a   Heinonen, Olli P ^a   Valle, Martti ^a   Paunio, Mikko ^a   Virtanen, Martti ^a   Karanko, Viena ^a   Cantell, Kari ^a  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MMR 2; UNCLASSIFIED DRUG;

ARTICLE; CHILD; FEVER; FINLAND; HUMAN; IMMUNIZATION; INFANT; INFECTION CONTROL; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MEASLES; MUMPS; PRIORITY JOURNAL; RUBELLA; THROMBOCYTOPENIC PURPURA; URTICARIA;

CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; DRUG COMBINATIONS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INFANT; MEASLES; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; MUMPS VACCINE; RUBELLA; RUBELLA VACCINE;

EID: 0027944223     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199411243312101     Document Type: Article

References (46)

1. Koskiniemi M, Vaheri A Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children. Lancet 1989; 1:31-34
2. Peltola H, Karanko V, Kurki T, Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Lancet 1986; 1:137-139
3. Anderson RM, May RM Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg (Lond) 1983; 90:259-325
4. Hethcote HW Measles and rubella in the United States. Am J Epidemiol 1983; 117:2-13
5. Penttinen K, Cantell K, Somer P, Poikolainen A Mumps vaccination in the Finnish Defense Forces. Am J Epidemiol 1968; 88:234-244
6. Vuori M, Lahikainen EA, Peltonen T Perceptive deafness in connection with mumps: a study of 298 servicemen suffering from mumps. Acta Otolaryngol (Stockh) 1962; 55:231-236
7. Vaheri A, Julkunen I, Koskiniemi M-L Chronic encephalomyelitis with specific increase in intrathecal mumps antibodies. Lancet 1982; 2:685-688
8. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, Mass.: Publishing Sciences Group, 1977:7-8, 89-91, 121-3, 137-8, 197.
9. Chantler JK, Tingle AJ, Petty RE Persistent rubella virus infection associated with chronic arthritis in children. N Engl J Med 1985; 313:1117-1123
10. Ueda K, Tokugawa K, Nishida Y, Kimura M Incidence of congenital rubella syndrome in Japan (1965-1985): a nationwide survey of the number of deaf children with history of maternal rubella attending special schools for the deaf in Japan. Am J Epidemiol 1986; 124:807-815
11. Peltola H, Heinonen OP Frequency of true adverse reactions to measles-mumps-rubella vaccine: a double-blind placebo-controlled trial in twins. Lancet 1986; 1:939-942
12. Juntunen-Backman K, Peltola H, Backman A, Salo OP Safe immunization of allergic children against measles, mumps, and rubella. Am J Dis Child 1987; 141:1103-1105
13. Paunio M, Virtanen M, Peltola H, Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland. Am J Epidemiol 1991; 133:1152-1160
14. Gershon AA, Krugman S. Measles virus. In: Lennette EH, Schmidt NJ, eds. Diagnostic procedures for viral, rickettsial and chlamydial infections. 5th ed. Washington, D.C.: American Public Health Association, 1979:685-6.
15. Vaananen P, Vaheri A Hemolysis-in-gel test in immunity surveys and diagnosis of rubella. J Med Virol 1979; 3:245-252
16. Weibel RE, Buynak EB, McLean AA, Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps, and rubella virus vaccines. Proc Soc Exp Biol Med 1980; 165:260-263
17. Weibel RE, Carlson AJ Jr, Villarejos VM, Buynak EB, McLean AA, Hilleman MR Clinical and laboratory studies of combined live measles, mumps, and rubella vaccines using the RA 27/3 rubella virus. Proc Soc Exp Biol Med 1980; 165:323-326
18. Christenson B, Bottiger M, Heller L, Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: first experience. BMJ 1983; 287:389-391
19. Vesikari T, Ala-Laurila E-L, Heikkinen A, Terho A, D'Hondt E, Andre FE Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children. Am J Dis Child 1984; 138:843-847
20. Lerman SJ, Bollinger M, Brunken JM Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination. Pediatrics 1981; 68:18-22
21. Diabetes Epidemiology Research International Group. Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes 1988; 37:1113-1119
22. Valmari P, Lanning M, Tuokko H, Kouvalainen K Measles virus in the cerebrospinal fluid in postvaccination immunosuppressive measles encephalopathy. Pediatr Infect Dis J 1987; 6:59-63
23. Nieminen U, Peltola H, Syrjala MT, Makipernaa A, Kekomaki R Acute thrombocytopenic purpura following measles, mumps and rubella vaccination: a report on 23 patients. Acta Paediatr 1993; 82:267-270
24. Ukkonen P, von Bonsdorff C-H Rubella immunity and morbidity: effects of vaccination in Finland. Scand J Infect Dis 1988; 20:255-259
25. Brunell PA, Weigle K, Murphy MD, Shehab Z, Cobb E Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA 1983; 250:1409-1412
26. Aaby P, Bukh J, Hoff G, High measles mortality in infancy related to intensity of exposure. J Pediatr 1986; 109:40-44
27. Howson CP, Fineberg HV The ricochet of magic bullets: summary of the Institute of Medicine Report, Adverse Effects of Pertussis and Rubella Vaccines. Pediatrics 1992; 89:318-324
28. Hudson JB, Weinstein L, Chang T-W Thrombocytopenic purpura in measles. J Pediatr 1956; 48:48-56
29. Graham DY, Brown CH III, Benrey J, Butel JS Thrombocytopenia: a complication of mumps. JAMA 1974; 227:1162-1164
30. Lokietz H, Reynolds FA Postrubella thrombocytopenic purpura: report of nine new cases and review of published cases. J Lancet 1965; 85:226-230
31. Bayer WL, Sherman FE, Michaels RH, Szeto ILF, Lewis JH Purpura in congenital and acquired rubella. N Engl J Med 1965; 273:1362-1366
32. Kiefaber RW Thrombocytopenic purpura after measles vaccination. N Engl J Med 1981; 305:225-225
33. Forrest JM, Honeyman MC, Lovric VA Rubella vaccination and thrombocytopenia. Aust N Z J Med 1974; 4:352-355
34. Peltola H Mumps vaccination and meningitis. Lancet 1993; 341:994-995
35. Markowitz LE, Albrecht P, Orenstein WA, Lett SM, Pugliese TJ, Farrell D Persistence of measles antibody after revaccination. J Infect Dis 1992; 166:205-208
36. Reported vaccine-preventable diseases United States, 1993, and the Childhood Immunization Initiative. MMWR Morb Mortal Wkly Rep 1994; 43:57-60
37. Hyoty H, Hiltunen M, Reunanen A, Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Diabetologia 1993; 36:1303-1308
38. Katz SL The politics of measles. Rep Pediatr Infect Dis 1991; 1:1-2
39. Wilkins J, Wehrle PF Additional evidence against measles vaccine administration to infants less than 12 months of age: altered immune response following active/passive immunization. J Pediatr 1979; 94:865-869
40. Ohga S, Okada K, Miyazaki C, Akazawa K, Ueda K The measles outbreak in Chikuhou District, Fukuoka, Japan, 1990: correlation between herd immunity level and outbreak size. Acta Paediatr Jpn 1992; 34:447-453
41. Cutts FT, Zell ER, Mason D, Bernier RH, Dini EF, Orenstein WA Monitoring progress toward US preschool immunization goals. JAMA 1992; 267:1952-1955
42. Edmonson MB, Addiss DG, McPherson JT, Berg JL, Circo SR, Davis JP Mild measles and secondary vaccine failure during a sustained outbreak in a a highly vaccinated population. JAMA 1990; 263:2467-2471
43. Galloway Y, Stehr-Green P Measles in New Zealand, 1991. Commun Dis N Z 1991; 12:107-109
44. Carter H, Gorman D Measles, mumps, and rubella vaccine: time for a two stage policy? BMJ 1992; 304:637-637
45. Lau Y-L, Chow C-B, Leung T-H Changing epidemiology of measles in Hong Kong from 1961 to 1990 impact of a measles vaccination program. J Infect Dis 1992; 165:1111-1115
46. Measles United States, 1992. MMWR Morb Mortal Wkly Rep 1993; 42:378-381